Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Completed 2Suspended 1

Sponsor Class

OTHER 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Breast 3Thoracic 1Plasma cell 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Neoplasms 12Breast Neoplasms 11Lung Neoplasms 6Prostatic Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Thyroid Neoplasms 2Smoking Cessation 2Motor Activity 2Lymphoma 2Hematologic Neoplasms 2Communication 2Uveal Melanoma 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Tobacco Use Cessation 1Thyroid Diseases 1Substance-Related Disorders 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Sexual Dysfunction, Physiological 1Sedentary Behavior 1Rectal Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Papillomavirus Infections 1Papillary Thyroid Microcarcinoma 1Neoplasms, Plasma Cell 1

Interventions

Fluorouracil 497Bevacizumab 476Oxaliplatin 449Leucovorin 440Irinotecan 408Cetuximab 317Capecitabine 317pembrolizumab 142Folfox protocol 129Panitumumab 117regorafenib 105Colonoscopy 88Nivolumab 81IFL protocol 81Drug Therapy 77trifluridine tipiracil drug combination 73Radiotherapy 66HMPL-013 65Blood Specimen Collection 52Gemcitabine 49Specimen Handling 46Neoadjuvant Therapy 45Standard of Care 44Magnetic Resonance Spectroscopy 43Biopsy 43Chemotherapy, Adjuvant 41Trifluridine 40atezolizumab 38Surveys and Questionnaires 38Cyclophosphamide 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Focus Groups × Clear all
NCT06666192 2025-12-24

The Ohio State University (OSU) SCREEN Community Program

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
2,067 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms

NCT04392050 2025-11-28

A Community-Based Educational Intervention to Improve Colorectal Cancer Screening

Thomas Jefferson University

Suspended
90 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06236373 2024-12-09

Survivorship

University of Modena and Reggio Emilia

Recruiting
45 enrolled
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cell

Breast Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Colorectal Neoplasms, Neoplasms, Plasma Cell

NCT02217865 2022-02-15

Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer

M.D. Anderson Cancer Center

Completed
32 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02565017 2020-06-25

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

Memorial Sloan Kettering Cancer Center

Completed
70 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡